Prostate cancer and the role of biomarkers.
Amihay NevoAnojan NavaratnamPaul AndrewsPublished in: Abdominal radiology (New York) (2021)
New biomarkers have improved risk stratification in diagnosing and treating prostate cancer. Many of these markers are still considered experimental, and their efficacy and cost utility have not been determined.
Keyphrases